Transplantation: Efficacy of rapid steroid withdrawal after induction therapy

Nature Reviews Nephrology 13, 2 (2017). doi:10.1038/nrneph.2016.179 Author: Andrea Aguilar New data from the Harmony trial show that in renal transplant recipients with a low immunological risk profile, rapid corticosteroid withdrawal after rabbit anti-thymocyte globulin (ATG) or basiliximab induction therapy can be achieved without compromising the efficacy of standard low-dose tacrolimus and mycophenolate mofetil (MMF)-based
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Research Highlight Source Type: research